Hong Kong-based healthcare-focused investment group Ally Bridge Group (ABG) has led an over-subscribed $65 million financing for Pulmonx Corporation, a California-based company in diagnostic and therapeutic pulmonary device technologies, according to a statement.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
